tiprankstipranks
Legend Biotech Corporation (DE:9LB)
FRANKFURT:9LB
Holding DE:9LB?
Track your performance easily

Legend Biotech (9LB) Cash flow

2 Followers

Legend Biotech Cash Flow

DE:9LB's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, DE:9LB's free cash flow was decreased by $-291.23M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -78.69M$ -393.28M$ -201.28M$ -198.47M$ -223.00M$ -83.07M
Investing Cash Flow
$ -232.50M$ 92.79M$ -77.09M$ -194.98M$ -24.17M$ -58.65M
Financing Cash Flow
$ 25.00K$ 791.49M$ 377.98M$ 626.66M$ 618.88M$ 14.67M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 377.79M$ 1.28B$ 1.40B$ 688.94M$ 455.69M$ 83.36M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-$ 583.69M-$ 623.44M$ 462.08M-
Issuance Of Debt
$ -434.00K$ -3.75M$ -2.60M$ -1.42M$ -2.60M$ -7.92M
Repayment Of Debt
$ -434.00K$ -3.75M$ -2.60M$ -1.42M$ -2.60M$ -7.92M
Free Cash Flow
$ -91.22M$ -514.78M$ -223.56M$ -198.47M$ -272.78M$ -122.16M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Legend Biotech Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis